Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
177.11
-2.79 (-1.55%)
At close: Apr 9, 2026, 4:00 PM EDT
176.80
-0.31 (-0.18%)
After-hours: Apr 9, 2026, 5:56 PM EDT
Biogen Stock Forecast
Stock Price Forecast
The 26 analysts that cover Biogen stock have a consensus rating of "Buy" and an average price target of $197.46, which forecasts a 11.49% increase in the stock price over the next year. The lowest target is $115 and the highest is $275.
Price Target: $197.46 (+11.49%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 8 | 8 | 8 |
| Buy | 4 | 4 | 5 | 4 | 4 | 4 |
| Hold | 14 | 12 | 14 | 15 | 15 | 14 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 23 | 25 | 28 | 28 | 27 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $228 → $237 | Strong Buy | Maintains | $228 → $237 | +33.82% | Apr 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $230 → $245 | Strong Buy | Maintains | $230 → $245 | +38.33% | Apr 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +55.27% | Apr 1, 2026 |
| HSBC | HSBC | Sell Maintains $143 → $150 | Sell | Maintains | $143 → $150 | -15.31% | Mar 17, 2026 |
| Freedom Broker | Freedom Broker | Hold Maintains $160 → $185 | Hold | Maintains | $160 → $185 | +4.45% | Feb 23, 2026 |
Financial Forecast
Revenue This Year
9.73B
from 9.89B
Decreased by -1.59%
Revenue Next Year
9.70B
from 9.73B
Decreased by -0.34%
EPS This Year
16.12
from 8.79
Increased by 83.42%
EPS Next Year
16.35
from 16.12
Increased by 1.40%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.6B | 10.8B | |||
| Avg | 9.7B | 9.7B | |||
| Low | 9.1B | 8.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 7.3% | 11.2% | |||
| Avg | -1.6% | -0.3% | |||
| Low | -8.3% | -12.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 17.14 | 19.08 | |||
| Avg | 16.12 | 16.35 | |||
| Low | 14.05 | 13.51 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 94.9% | 18.4% | |||
| Avg | 83.4% | 1.4% | |||
| Low | 59.9% | -16.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.